Dr. Sato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
Philadelphia, PA 19107Phone+1 215-955-3158Fax+1 215-955-9600
Education & Training
Jichi Medical UniversityPh.D., Tumor Immunology, 1991
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHPost-Doctoral Fellowship, Hematology and Medical Oncology, 1997 - 2000- Sidney Kimmel Medical College at Thomas Jefferson UniversityResidency, Post-Doctral Fellow, 2000
Tokyo Medical and Dental UniversityClass of 1980
Certifications & Licensure
PA State Medical License 1992 - 2026
Japanese Society of PediatricsPediatrics
Clinical Trials
- Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors Start of enrollment: 2020 Feb 25
- Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma Start of enrollment: 2021 Jan 26
Publications & Presentations
PubMed
- Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies.Juanita S Lopez, Mohammed Milhem, Marcus O Butler, Fiona Thistlethwaite, Brian A Van Tine
Cell Reports. Medicine. 2025-02-27 - Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress.Vivian Chua, Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai
Science Signaling. 2024-06-11 - 2 citationsLong-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel
Journal for Immunotherapy of Cancer. 2024-06-06
Press Mentions
Research Provides Clues to Improving CAR-T for Solid TumorsNovember 30th, 2021
Combination Treatments May Improve Survival for Patients with Metastatic Uveal MelanomaFebruary 6th, 2020
Shift in Treatment Modalities Associated with Improved Outcomes in Uveal Melanoma Patients with LiveFebruary 3rd, 2020- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Japanese
External Links
- TJUhttps://pulse.jefferson.edu/webapps/portal/frameset.jsp
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
